Created at Source Raw Value Validated value
March 11, 2022, 3:30 p.m. oms

1. COPD and asthma treated with ICS in the past 4 week 2. had recent use (within 7 days) of inhaled or systemic glucocorticoids 3. had a known allergy or contraindication to inhaled budesonide 4. subjects who have participated in the other clinical trial

1. COPD and asthma treated with ICS in the past 4 week 2. had recent use (within 7 days) of inhaled or systemic glucocorticoids 3. had a known allergy or contraindication to inhaled budesonide 4. subjects who have participated in the other clinical trial